Condition
Myeloid
Total Trials
3
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
Early P 1 (1)
P 1 (1)
Trial Status
Not Yet Recruiting1
Recruiting1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT05673057Phase 1Recruiting
Study of MP0533 in Patients Acute Myeloid Leukemia or Myelodysplastic Syndrome
NCT07123662Early Phase 1Not Yet Recruiting
γδ T Cell Therapy for Relapse Prevention in High-Risk AML Post-Transplant
NCT02584296Not ApplicableCompleted
Physical Activity as Self-Management Approach to Improve Health Outcomes in AML
Showing all 3 trials